Characteristic | Persons with dementia (N=2024) | Persons without dementia (N=2024) | P value* | ||||
n | % or Mean | SD | n | % or Mean | SD | ||
Propensity score (mean) | 2024 | 0.024 | 0.0165 | 2024 | 0.024 | 0.0164 | 1.00 |
Age group (%) | |||||||
65–69 | 488 | 24.11 | 0.43 | 488 | 24.22 | 0.43 | 1.00 |
70–74 | 276 | 13.64 | 0.34 | 276 | 13.64 | 0.34 | 1.00 |
75–79 | 280 | 13.83 | 0.35 | 280 | 13.83 | 0.35 | 1.00 |
80–84 | 374 | 18.48 | 0.39 | 375 | 18.53 | 0.39 | 0.97 |
85+ | 606 | 29.94 | 0.46 | 605 | 28.89 | 0.46 | 0.97 |
Male sex (%) | 802 | 39.62 | 0.49 | 801 | 38.58 | 0.49 | 0.97 |
Urban residence (%) | 1407 | 69.42 | 0.46 | 1405 | 69.52 | 0.46 | 0.95 |
Charlson Comorbidity Index score, 1 year prior (mean) | 2024 | 0.77 | 1.35 | 2024 | 0.77 | 1.36 | 0.96 |
Geographical region (%) | |||||||
Northern SK | 21 | 1.04 | 0.10 | 21 | 1.04 | 0.10 | 1.00 |
Central SK | 1174 | 58.0 | 0.49 | 1173 | 58.0 | 0.49 | 0.97 |
Southern SK | 829 | 41.0 | 0.49 | 830 | 41.0 | 0.49 | 0.97 |
*χ2 test at 5% level of significance.